Amino Collective invests in radical, free-thinking founders building life-changing solutions at the intersection of health, biology, and AI. They focus on early-stage companies with a European origin and global scaling potential, leveraging AI, precision medicine, and innovative scientific approaches to address unmet medical needs and transform industries like drug discovery, diagnostics, and healthcare delivery.
Bevorzugte Reifephase für die erste Finanzierung.
Early-stage ventures in health, bio, and AI-driven scientific innovation with a European focus and global scaling ambition.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...